Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuronetics (STIM) Capital Expenditures (2017 - 2025)

Neuronetics (STIM) has disclosed Capital Expenditures for 9 consecutive years, with $24000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Capital Expenditures fell 97.97% to $24000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was -$1.3 million, a 159.13% decrease, with the full-year FY2024 number at $13000.0, down 99.45% from a year prior.
  • Capital Expenditures was $24000.0 for Q3 2025 at Neuronetics, up from -$37000.0 in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $2.5 million in Q3 2022 to a low of -$2.7 million in Q4 2022.
  • A 5-year average of $256210.5 and a median of $186000.0 in 2021 define the central range for Capital Expenditures.
  • Biggest YoY gain for Capital Expenditures was 11800.0% in 2021; the steepest drop was 935.71% in 2021.
  • Neuronetics' Capital Expenditures stood at $2.0 million in 2021, then tumbled by 236.21% to -$2.7 million in 2022, then skyrocketed by 133.01% to $879000.0 in 2023, then crashed by 255.18% to -$1.4 million in 2024, then soared by 101.76% to $24000.0 in 2025.
  • Per Business Quant, the three most recent readings for STIM's Capital Expenditures are $24000.0 (Q3 2025), -$37000.0 (Q2 2025), and $43000.0 (Q1 2025).